Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma.
about
Approaches for targeted proteomics and its potential applications in neuroscienceCDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma CellsBET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor ModelsApplication of proteomics to soft tissue sarcomasDidymin: an orally active citrus flavonoid for targeting neuroblastoma.Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status.Identifier mapping performance for integrating transcriptomics and proteomics experimental results.Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcomeQuantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma.Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cellsHigh genomic instability predicts survival in metastatic high-risk neuroblastoma.Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancersMolecular imaging of neuroblastoma progression in TH-MYCN transgenic mice.Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34aMulti-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research.BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery.Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer.Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use.Myc, Oncogenic Protein Translation, and the Role of Polyamines.
P2860
Q26786427-DC15714E-1458-4DF4-948E-22726F0CDFC4Q27670943-CAD4C367-83EC-4FC5-B0D2-0F9525BFF69AQ27679878-1F85A221-3C03-473A-95CA-6BBA64001482Q28385995-4018C614-A557-4C85-BEA8-9CEB4038E476Q33710161-437F3388-8F5F-40D6-B726-6A3040EC2267Q33875892-A86B8558-C362-4285-B0E3-CD0CD141F8BEQ33914346-F2455F94-EE7B-4C7B-8B71-A3CA4234A9A5Q34247959-CDF1A996-590C-4904-AAA9-25C66DE2D0A0Q35070321-DD930A2C-AE20-4104-BF72-F20D640DF50BQ35148549-9712C30A-B8DD-47AB-B61A-CCE12112B130Q36282735-F5BB492A-0B49-4600-899A-CF378E900630Q36470331-BFE1431E-FC5B-470B-A608-84EC7EE08564Q36673633-D9B35CAF-1928-4A08-8CAB-06924BC7B0E9Q36921032-E0309A0C-E36F-41C4-9F2F-164D6E4F79F2Q37668003-C40A28E5-0769-4711-B11F-B504C51BD2E6Q38113846-031E93F2-AF1D-4B63-9EE3-3692FCBF304AQ39245718-D8633E58-F6E7-49B1-A8EA-567422679465Q39700283-B525976A-0D0D-413A-8515-F1591042F2B2Q40126367-DD3FBCD4-BD0D-4B53-80A9-6FCDF9C9BE6BQ49160323-5356F46D-566F-4E37-93BB-443C584045BFQ55414287-4C125D77-814C-4E3D-93FB-16CA8BAB3B10
P2860
Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@ast
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@en
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@nl
type
label
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@ast
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@en
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@nl
prefLabel
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@ast
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@en
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@nl
P2093
P2860
P356
P1476
Global genomic and proteomic a ...... ed to high-risk neuroblastoma.
@en
P2093
Javed Khan
Li-Rong Yu
Qing-Rong Chen
Timothy D Veenstra
Young K Song
P2860
P304
P356
10.1021/PR900701V
P577
2010-01-01T00:00:00Z